Published in Chromosoma on August 28, 2013
X chromosome inactivation: recent advances and a look forward. Curr Opin Genet Dev (2014) 0.86
Incorporation of 5-ethynyl-2'-deoxyuridine (EdU) as a novel strategy for identification of the skewed X inactivation pattern in balanced and unbalanced X-rearrangements. Hum Genet (2015) 0.82
Single-Cell XIST Expression in Human Preimplantation Embryos and Newly Reprogrammed Female Induced Pluripotent Stem Cells. Stem Cells (2015) 0.82
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature (2010) 18.63
Stability and flexibility of epigenetic gene regulation in mammalian development. Nature (2007) 14.57
Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature (2011) 9.33
Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med (2004) 8.89
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell (2012) 3.80
Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nat Cell Biol (2006) 3.66
5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol (2011) 3.48
Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis. Genome Res (2009) 3.36
Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev Cell (2013) 3.31
X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A (2008) 3.25
Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet (2011) 2.87
Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle (2010) 2.64
Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature (2012) 2.64
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature (2013) 2.63
Female human iPSCs retain an inactive X chromosome. Cell Stem Cell (2010) 2.59
X-Inactivation and histone H4 acetylation in embryonic stem cells. Dev Biol (1996) 2.50
H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet (2012) 2.47
Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell (2012) 2.42
Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet (2011) 2.39
Analysis of deoxyribonucleic acid replication in human X chromosomes by fluorescence microscopy. Am J Hum Genet (1976) 1.90
Mechanisms and consequences of widespread random monoallelic expression. Nat Rev Genet (2012) 1.81
Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome. Proc Natl Acad Sci U S A (2004) 1.80
DNA methylation profiles of human active and inactive X chromosomes. Genome Res (2011) 1.68
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res (2010) 1.27
Evolutionary diversity and developmental regulation of X-chromosome inactivation. Hum Genet (2011) 1.20
Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells. PLoS One (2011) 1.01
Histone acetylation controls the inactive X chromosome replication dynamics. Nat Commun (2011) 1.00
Error-prone nonhomologous end joining repair operates in human pluripotent stem cells during late G2. Aging (Albany NY) (2011) 0.98
Establishment of epigenetic patterns in development. Chromosoma (2012) 0.90
Chromosome-wide regulation of euchromatin-specific 5mC to 5hmC conversion in mouse ES cells and female human somatic cells. Chromosome Res (2012) 0.88
Human embryonic stem cell lines isolation, cultivation, and characterization. In Vitro Cell Dev Biol Anim (2010) 0.83
It's all in the timing: linking S phase to chromatin structure and chromosome dynamics. Cell Cycle (2003) 0.82
The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome. Cell Cycle (2012) 0.77
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle (2010) 2.64
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A (2005) 1.28
Error-prone nonhomologous end joining repair operates in human pluripotent stem cells during late G2. Aging (Albany NY) (2011) 0.98
Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol Cell Biol (2006) 0.90
Multiple Rabaptin-5-like transcripts. Gene (2002) 0.86
Apoptotic cleavage of rabaptin-5-like proteins and a model for rabaptin-5 inactivation in apoptosis. Cell Cycle (2006) 0.85
Pro-survival activity of the MAK-V protein kinase in PC12 cells. Cell Cycle (2010) 0.83
Sensitivity of human embryonic and induced pluripotent stem cells to a topoisomerase II poison etoposide. Cell Cycle (2011) 0.80
De novo reestablishment of gap junctional intercellular communications during reprogramming to pluripotency and differentiation. Stem Cells Dev (2012) 0.79
RAP80/UIMC1 as cancer-associated antigen: alternative splice variants and their immunogenicity. Cancer Lett (2007) 0.78
Subcellular localization of MAK-V/Hunk protein kinase expressed in COS-1 cells. Cell Biol Int (2004) 0.78
Current progress and potential practical application for human pluripotent stem cells. Int Rev Cell Mol Biol (2011) 0.77
CD 30 is a marker of undifferentiated human embryonic stem cells rather than a biomarker of transformed hESCs. Cell Cycle (2008) 0.77
Agrobacterium tumefaciens-induced bacteraemia does not lead to reporter gene expression in mouse organs. PLoS One (2008) 0.77
Serological identification of antigens associated with renal cell carcinoma. Russ J Immunol (2002) 0.76
Cloning and developmental expression of MARK/Par-1/MELK-related protein kinase xMAK-V in Xenopus laevis. Dev Genes Evol (2004) 0.76
Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy. Immunol Lett (2005) 0.76
Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients. Int J Cancer (2005) 0.75